Advanced Accelerator Applications (AAAP) Stock Price, News & Analysis

Company Overview

Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer. The Company has a portfolio of nine diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. PET and SPECT are imaging techniques in molecular nuclear diagnostics (MND) with applications in clinical oncology, cardiology, neurology and inflammatory/infectious diseases. Its commercial products include Gluscan/Gluscan 500/Barnascan, FluoroChol, MIBITEC/Adamibi, DOPAVIEW, Leukokit, Neurolite, SomaKit and NETSPOT. Additional MND product candidates include Annexin V-128, a SPECT product candidate for the imaging of apoptotic and necrotic lesions with potential applications in a range of indications.

Key Stats

• Today's Range: $81.63 to $81.63
• 50-Day Range: N/A
• 52-Week Range: $35.11 to $82.74
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AAAP Stock Analysis - Frequently Asked Questions

How were Advanced Accelerator Applications' earnings last quarter?

Advanced Accelerator Applications (NASDAQ:AAAP) issued its quarterly earnings results on Thursday, August, 31st. The company reported ($0.13) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. The firm had revenue of $40.14 million for the quarter, compared to analysts' expectations of $36.74 million.

When did Advanced Accelerator Applications IPO?

Advanced Accelerator Applications (AAAP) raised $76 million in an IPO on Thursday, February 5th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What other stocks do shareholders of Advanced Accelerator Applications own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Accelerator Applications investors own include Comerica (CMA), Honda Motor (HMC), Albemarle (ALB), Clinigen Group (CLIN), Directa Plus (DCTA), Editas Medicine (EDIT) and First Hawaiian (FHB).

Company Calendar

• Last Earnings: 8/31/2017
• Today: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:AAAP
• CIK: N/A
• Web: www.adacap.com
• Phone: 33-04-50-99-30-70
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A